Senseonics Holdings, Inc. to Participate in the Sidoti Small Cap Conference

Rhea-AI Summary

Senseonics Holdings, a medical technology firm specializing in long-term, implantable continuous glucose monitoring (CGM) systems, announces its participation in the Sidoti Small Cap Conference. The event will take place virtually on June 12, 2024, at 1:45 pm ET. Management will hold one-on-one meetings and present key insights. The live and recorded webcast of the presentation will be available on the company's Investor Relations section at www.senseonics.com.

Positive

• Senseonics Holdings is participating in the Sidoti Small Cap Conference, indicating active engagement with the investment community.
• Potential to attract new investors through the one-on-one meetings and presentation.
• Provides a platform for Senseonics to showcase its long-term CGM systems to a broader audience.

Negative

• No new financial data or clinical updates were provided in the PR.
• The announcement may not significantly impact stock performance without additional substantial news.
• Participating in the conference requires resources without immediate guaranteed returns.

GERMANTOWN, Md.--(BUSINESS WIRE)-- Senseonics Holdings, Inc. (NYSE American: SENS), a medical technology company focused on the development and manufacturing of long-term, implantable continuous glucose monitoring (CGM) systems for people with diabetes, today announced plans to participate in the upcoming Sidoti Small Cap Conference, being held in virtually.

Management is scheduled to participate on Wednesday, June 12, 2024, at 1:45 pm ET and will hold one-on-one meetings. Interested parties may access a live and recorded webcast of the presentation on the “Investor Relations” section of the company’s website at www.senseonics.com.

About Senseonics

Senseonics Holdings, Inc. (“Senseonics”) is a medical technology company focused on the development and manufacturing of glucose monitoring products designed to transform lives in the global diabetes community with differentiated, long-term implantable glucose management technology. Senseonics’ CGM system Eversense® E3 includes a small sensor inserted completely under the skin that communicates with a smart transmitter worn over the sensor. The glucose data are automatically sent every 5 minutes to a mobile app on the user’s smartphone.

View source version on businesswire.com: https://www.businesswire.com/news/home/20240529738025/en/

Senseonics Investor Contact

Philip Taylor

Gilmartin Group

415-937-5406

Investors@senseonics.com

Source: Senseonics Holdings, Inc.

FAQ

What is the Sidoti Small Cap Conference?

The Sidoti Small Cap Conference is a virtual event where small-cap companies present their business strategies and developments to investors.

When will Senseonics Holdings present at the Sidoti Small Cap Conference?

Senseonics Holdings will present on June 12, 2024, at 1:45 pm ET.

What is the focus of Senseonics Holdings' presentation at the Sidoti Small Cap Conference?

Senseonics Holdings will focus on its long-term, implantable continuous glucose monitoring (CGM) systems.

Where can I access the Senseonics Holdings' presentation for the Sidoti Small Cap Conference?

The presentation will be available on the Investor Relations section of Senseonics Holdings' website at www.senseonics.com.

What is the stock symbol for Senseonics Holdings?

The stock symbol for Senseonics Holdings is SENS.